Inula Viscosa Extracts Induces Telomere Shortening and Apoptosis in Cancer Cells and Overcome Drug Resistance

References

• Agosti JM and Goldie SJ: Introducing HPV vaccine in developing countries–key challenges and issues. N Engl J Med 356, 1908–1910, 2007.
   PubMed Web of Science ®Google Scholar
• Marongiu L, Godi A, Parry JV, and Beddows S: Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage. BMC Cancer 14, 384, 2014.
   PubMed Web of Science ®Google Scholar
• Munger K, Phelps WC, Bubb V, Howley PM, and Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417–4421, 1989.
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley PM, Munger K, and Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934–937, 1994.
   Web of Science ®Google Scholar
• Scheffner M, Munger K, Byrne JC, and Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 88, 5523–5527, 1991.
   PubMed Web of Science ®Google Scholar
• Vande Pol SB and Klingelhutz AJ: Papillomavirus E6 oncoproteins. Virology 445, 115–137, 2013.
   PubMed Web of Science ®Google Scholar
• Zhang DK, Ngan HY, Cheng RY, Cheung AN, Liu SS, et al.: Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer 35, 154–160, 1999.
   PubMed Web of Science ®Google Scholar
• Kelland L: Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res 13, 4960–4963, 2007.
   PubMed Web of Science ®Google Scholar
• Mizushina Y, Takeuchi T, Sugawara F, and Yoshida H: Anti-cancer targeting telomerase inhibitors: beta-rubromycin and oleic acid. Mini Rev Med Chem 12, 1135–1143, 2008.
   PubMed Web of Science ®Google Scholar
• De Cian A, Lacroix L, Douarre C, Temime-Smaali N, Trentesaux C, et al.: Targeting telomeres and telomerase. Biochimie 90, 131–155, 2008.
   PubMed Web of Science ®Google Scholar
• Echiburu-Chau C, Alfaro-Lira S, Brown N, Salas CO, Cuellar M, et al.: The selective cytotoxicity elicited by phytochemical extract from Senecio graveolens (Asteraceae) on breast cancer cells is enhanced by hypoxia. International Journal of Oncology 44, 1357–1364, 2014.
   PubMed Web of Science ®Google Scholar
• Kucekova Z, Mlcek J, Humpolicek P, Rop O, Valasek P, et al.: Phenolic compounds from Allium schoenoprasum, Tragopogon pratensis and Rumex acetosa and their antiproliferative effects. Molecules 16, 9207–9217, 2011.
   PubMed Web of Science ®Google Scholar
• Parolin P, Ion Scotta M, and Bresch C: Dittrichia viscosa, a Mediterranean ruderal plant. International Journal of Experimental Botany 83, 251--262, 2014.
   Web of Science ®Google Scholar
• Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, and Jouad H: Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol 82, 97–103, 2002.
   PubMed Web of Science ®Google Scholar
• Hernandez V, Recio MC, Manez S, Giner RM, and Rios JL: Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism. Life Sci 81, 480–488, 2007.
   PubMed Web of Science ®Google Scholar
• Manez S, Recio MC, Gil I, Gomez C, Giner RM, et al.: A glycosyl analogue of diacylglycerol and other antiinflammatory constituents from Inula viscosa. J Nat Prod 62, 601–604, 1999.
   PubMed Web of Science ®Google Scholar
• Zeggwagh NA, Ouahidi ML, Lemhadri A, and Eddouks M: Study of hypoglycaemic and hypolipidemic effects of Inula viscosa L. aqueous extract in normal and diabetic rats. J Ethnopharmacol 108, 223–227, 2006.
   PubMed Web of Science ®Google Scholar
• Maoz M and Neeman I: Antimicrobial effects of aqueous plant extracts on the fungi Microsporum canis and Trichophyton rubrum and on three bacterial species. Lett Appl Microbiol 26, 61–63, 1998.
   PubMed Web of Science ®Google Scholar
• Gokbulut A, Ozhan O, Satilmis B, Batcioglu K, Gunal S, et al.: Antioxidant and antimicrobial activities, and phenolic compounds of selected Inula species from Turkey. Nat Prod Commun 8, 475–478, 2013.
   PubMed Web of Science ®Google Scholar
• Talib WH, Zarga MH, and Mahasneh AM: Antiproliferative, antimicrobial and apoptosis inducing effects of compounds isolated from Inula viscosa. Molecules 17, 3291–3303, 2012.
   PubMed Web of Science ®Google Scholar
• Bar-Shalom RF: The anti-cancer effect of inula viscosa extract on colorectal cancer cell growth using in vitro and in vivo systems. Anticancer Research 34, 5761–6258, 2014.
   Web of Science ®Google Scholar
• Schneider E, Horton JK, Yang CH, Nakagawa M, and Cowan KH: Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54, 152–158, 1994.
   PubMed Web of Science ®Google Scholar
• Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, et al.: Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47, 5141–5148, 1987.
   PubMed Web of Science ®Google Scholar
• Naredi P, Heath DD, Enns RE, and Howell SB: Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line. Cancer Res 54, 6464–6468, 1994.
   PubMed Web of Science ®Google Scholar
• Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, et al.: Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 60, 5269–5277, 2000.
   PubMed Web of Science ®Google Scholar
• Schurr E, Raymond M, Bell JC, and Gros P: Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. Cancer Res 49, 2729–2733, 1989.
   PubMed Web of Science ®Google Scholar
• Azzaria M, Schurr E, and Gros P: Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol Cell Biol 9, 289–5297, 1989.
   Web of Science ®Google Scholar
• Robey RW, Honjo Y, Morisaki K, Nadjem TA, Runge S, et al.: Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer 89, 1971–1978, 2003.
   PubMed Web of Science ®Google Scholar
• Cerone MA, Londono-Vallejo JA, and Bacchetti S: Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet 10, 1945–1952, 2001.
   PubMed Web of Science ®Google Scholar
• Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, et al.: Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40, 797–806, 2003.
   PubMed Web of Science ®Google Scholar
• Gomez D, Aouali N, Londono-Vallejo A, Lacroix L, Megnin-Chanet F, et al.: Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J Biol Chem 278, 50554–50562, 2003.
   PubMed Web of Science ®Google Scholar
• Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55–63, 1983.
   PubMed Web of Science ®Google Scholar
• Douarre C, Gomez D, Morjani H, Zahm JM, O'Donohue MF, et al.: Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res 33, 2192–2203, 2005.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fang MY, Jiang F, and Peng HJ: [Effects of arsenic trioxide, ginseng saponin and beta-elemene on telomere-telomerase system in K562 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12, 315–320, 2004.
   PubMedGoogle Scholar
• Tang FY, Chiang EP, and Sun YC: Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem 19, 287–294, 2008.
   PubMed Web of Science ®Google Scholar
• Sadava D, Whitlock E, and Kane SE: The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun 360, 233–237, 2007.
   PubMed Web of Science ®Google Scholar
• Park C, Jin CY, Kwon HJ, Hwang HJ, Kim GY, et al.: Induction of apoptosis by esculetin in human leukemia U937 cells: roles of Bcl-2 and extracellular-regulated kinase signaling. Toxicol In Vitro 24, 486–494, 2007.
   Web of Science ®Google Scholar
• Park JS, Cheong JY, Kang JK, Cho JH, Yu S, et al.: [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma]. Korean J Gastroenterol 50, 313–318, 2007.
   PubMedGoogle Scholar
• Merghoub N, Benbacer L, Amzazi S, Morjani H, and El Mzibri M: Cytotoxic effect of some Moroccan medicinal plant extracts on human cervical cell lines. Journal of Medicinal Plants Research 3, 1045–1050, 2009.
   Google Scholar
• Benbacer L, Merghoub NM, El Btaouri H, Gmouh S, Attaleb M, et al.: Antiproliferative Effect and induction of apoptosis by Inula viscosa L. and Retama monosperma L. extracts in human cervical cancer cells. Topics on Cervical Cancer with an Advocacy for Prevention 16, 267–284, 2012.
   Google Scholar
• Suffness M, and Pezzuto JM: Assays related to cancer drug discovery. In: Methods in Plant Biochemistry (vol. 6), Hostettmann K, Ed. London: Academy Press, 1990, 71–133.
   Google Scholar
• Konishi T, Shimada Y, Nagao T, Okabe H, and Konoshima T: Antiproliferative sesquiterpene lactones from the roots of Inula helenium. Biol Pharm Bull 25, 1370–1372, 2002.
   PubMed Web of Science ®Google Scholar
• Spiridonov NA, Konovalov DA, and Arkhipov VV: Cytotoxicity of some Russian ethnomedicinal plants and plant compounds. Phytother Res 19, 428–432, 2005.
   PubMed Web of Science ®Google Scholar
• Dorn DC, Alexenizer M, Hengstler JG, and Dorn A: Tumor cell specific toxicity of Inula helenium extracts. Phytother Res 20, 970–980, 2006.
   PubMed Web of Science ®Google Scholar
• Talib WH and Mahasneh AM: Antiproliferative activity of plant extracts used against cancer in traditional medicine. Sci Pharm 78, 33–45, 2010.
   PubMedGoogle Scholar
• Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny JL, et al.: Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 32, 371–379, 2004.
   PubMed Web of Science ®Google Scholar
• Zarga MH, Sabri SS, Hamed EM, Khanfar MA, Zeller KP, et al.: A new eudesmane type sesquiterpene from Inula viscosa. Nat Prod Res 17, 99–102, 2003.
   PubMed Web of Science ®Google Scholar
• Fontana G, La Rocca S, Passannanti S, and Paternostro MP: Sesquiterpene compounds from Inula viscosa. Nat Prod Res 21, 824–827, 2007.
   PubMed Web of Science ®Google Scholar
• Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y, et al.: Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol 75, 369–382, 2008.
   PubMed Web of Science ®Google Scholar
• Costantino VV, Mansilla SF, Speroni J, Amaya C, Cuello-Carrion D, et al.: The sesquiterpene lactone dehydroleucodine triggers senescence and apoptosis in association with accumulation of DNA damage markers. PLoS One 8(1), e53168, 2013.
   PubMed Web of Science ®Google Scholar
• Huang PR, Yeh YM, and Wang TC: Potent inhibition of human telomerase by helenalin. Cancer Lett 227, 169–174, 2005.
   PubMed Web of Science ®Google Scholar
• Choi SH, Im E, Kang HK, Lee JH, Kwak HS, et al.: Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Lett 227, 153–162, 2005.
   PubMed Web of Science ®Google Scholar
• Kanno S, Kitajima Y, Kakuta M, Osanai Y, Kurauchi K, et al.: Costunolide-induced apoptosis is caused by receptor-mediated pathway and inhibition of telomerase activity in NALM-6 cells. Biol Pharm Bull 31, 1024–1028, 2008.
   PubMed Web of Science ®Google Scholar